Vassilios Atsaves

Ludwig Cancer Research · CH

Area of research

Molecular Biology · Pathology and Forensic Medicine

Research interest

Research interests include Lymphoma Diagnosis and Treatment, Heme Oxygenase-1 and Carbon Monoxide, Cancer-related Molecular Pathways, and Ubiquitin and proteasome pathways.

h-index

citations

987

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

AP-1 Transcription Factors as Regulators of Immune Responses in Cancer

Cancers 2019cited by 292position: firstdoi

PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma

Leukemia 2017cited by 188position: firstdoi

Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways

Oncogene 2012cited by 100position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

George Z. Rassidakis · Karolinska University Hospital2 papers (2017–2019)Vasiliki Leventaki · The University of Texas MD Anderson Cancer Center2 papers (2017–2019)Dimitris Chioureas · Karolinska Institutet1 papers (2017–2017)Dan Grandér · Karolinska Institutet1 papers (2017–2017)— · 1 papers (2017–2017)Q. Zhang · Fourth Affiliated Hospital of Harbin Medical University1 papers (2012–2012)Huiling Yang · Shihezi University1 papers (2012–2012)François X. Claret · The University of Texas at Austin1 papers (2012–2012)Lóránd Kis · Karolinska University Hospital1 papers (2017–2017)L. Jeffrey Medeiros · Universidade Federal de Pernambuco1 papers (2017–2017)Ken H. Young · Duke Medical Center1 papers (2017–2017)Nikolaos Tsesmetzis · Karolinska Institutet1 papers (2017–2017)Yunbao Pan · Wuhan University1 papers (2012–2012)Francois X. Claret · The University of Texas at Austin1 papers (2019–2019)Theocharis Panaretakis · The University of Texas MD Anderson Cancer Center1 papers (2017–2017)